FR2366311A1 - Procede pour la preparation de steroides polyhalogenes utiles comme medicaments - Google Patents

Procede pour la preparation de steroides polyhalogenes utiles comme medicaments

Info

Publication number
FR2366311A1
FR2366311A1 FR7729043A FR7729043A FR2366311A1 FR 2366311 A1 FR2366311 A1 FR 2366311A1 FR 7729043 A FR7729043 A FR 7729043A FR 7729043 A FR7729043 A FR 7729043A FR 2366311 A1 FR2366311 A1 FR 2366311A1
Authority
FR
France
Prior art keywords
polyhalogenic
preparation
medicinal products
steroids useful
alpha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7729043A
Other languages
English (en)
French (fr)
Other versions
FR2366311B1 (de
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of FR2366311A1 publication Critical patent/FR2366311A1/fr
Application granted granted Critical
Publication of FR2366311B1 publication Critical patent/FR2366311B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C07J71/0015—Oxiranes at position 9(11)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR7729043A 1976-09-29 1977-09-27 Procede pour la preparation de steroides polyhalogenes utiles comme medicaments Granted FR2366311A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU75903A LU75903A1 (de) 1976-09-29 1976-09-29

Publications (2)

Publication Number Publication Date
FR2366311A1 true FR2366311A1 (fr) 1978-04-28
FR2366311B1 FR2366311B1 (de) 1982-12-03

Family

ID=19728370

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7729043A Granted FR2366311A1 (fr) 1976-09-29 1977-09-27 Procede pour la preparation de steroides polyhalogenes utiles comme medicaments

Country Status (24)

Country Link
JP (1) JPS5356652A (de)
AT (3) AT363197B (de)
AU (1) AU514200B2 (de)
BE (1) BE859120A (de)
CA (1) CA1101410A (de)
CH (9) CH624967A5 (de)
CY (1) CY1178A (de)
DD (1) DD133150A5 (de)
DE (1) DE2743069C2 (de)
DK (1) DK146017C (de)
ES (1) ES462763A1 (de)
FR (1) FR2366311A1 (de)
GB (1) GB1563638A (de)
HK (1) HK16683A (de)
HU (1) HU175218B (de)
IE (1) IE46047B1 (de)
IL (1) IL53012A (de)
KE (1) KE3258A (de)
LU (1) LU75903A1 (de)
MY (1) MY8400092A (de)
NL (1) NL7710089A (de)
SE (1) SE436751B (de)
SG (1) SG3383G (de)
ZA (1) ZA775800B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL187577C (nl) * 1978-04-05 1991-11-18 Sibla Srl 3-acetoxy-9beta,11beta-epoxy-pregna-1,3,5-trienen, werkwijze voor de bereiding daarvan en werkwijze voor de bereiding van 6alfa-halogeen-pregna-1,4-dieen-3-onen.
DE3227312A1 (de) * 1982-07-19 1984-01-19 Schering AG, 1000 Berlin und 4709 Bergkamen Neue 6,16-dimethylkortikoide, ihre herstellung und verwendung
EP0523132A1 (de) * 1990-03-27 1993-01-20 Schering Corporation Verfahren zur dehydrierung von 9-alpha-hydroxy-steroiden
US5972922A (en) * 1990-06-11 1999-10-26 Alcon Laboratories, Inc. Steroids which inhibit angiogenesis
CA2473471A1 (en) 2001-11-29 2003-06-12 Taro Pharmaceuticals U.S.A., Inc. Method for the preparation of 6-alpha-fluoro corticosteroids
US8809307B2 (en) 2010-11-22 2014-08-19 Dow Pharmaceutical Sciences, Inc. Pharmaceutical formulations containing corticosteroids for topical administration
US11957753B2 (en) 2010-11-22 2024-04-16 Bausch Health Ireland Limited Pharmaceutical formulations containing corticosteroids for topical administration
AU2016279801B2 (en) 2015-06-18 2021-09-09 Valeant Pharmaceuticals North America Topical compositions comprising a corticosteroid and a retinoid for treating psoriasis

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3644340A (en) * 1970-03-19 1972-02-22 Syntex Corp Preparation of 21-chloro steroids
US3992422A (en) * 1975-08-14 1976-11-16 Schering Corporation Process for the preparation of 21-halogeno-21-desoxy-17α-acyloxy-20-keto-pregnenes

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB898292A (en) * 1959-03-18 1962-06-06 Upjohn Co Improvements in or relating to steroids and the manufacture thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3644340A (en) * 1970-03-19 1972-02-22 Syntex Corp Preparation of 21-chloro steroids
US3992422A (en) * 1975-08-14 1976-11-16 Schering Corporation Process for the preparation of 21-halogeno-21-desoxy-17α-acyloxy-20-keto-pregnenes

Also Published As

Publication number Publication date
AT363197B (de) 1981-07-10
BE859120A (fr) 1978-03-28
CH632521A5 (en) 1982-10-15
ZA775800B (en) 1978-08-30
IE46047L (en) 1978-03-29
CA1101410A (en) 1981-05-19
DK146017C (da) 1983-10-24
JPS5356652A (en) 1978-05-23
CH625809A5 (en) 1981-10-15
CY1178A (en) 1983-06-10
DK146017B (da) 1983-05-24
GB1563638A (en) 1980-03-26
HU175218B (hu) 1980-06-28
AU2914877A (en) 1979-04-05
FR2366311B1 (de) 1982-12-03
DE2743069C2 (de) 1987-03-05
IL53012A (en) 1982-05-31
ES462763A1 (es) 1978-05-16
HK16683A (en) 1983-05-27
AT363203B (de) 1981-07-27
NL7710089A (nl) 1978-03-31
IE46047B1 (en) 1983-02-09
SG3383G (en) 1983-09-09
AT363202B (de) 1981-07-27
CH632279A5 (en) 1982-09-30
CH625808A5 (en) 1981-10-15
ATA691077A (de) 1980-12-15
CH631999A5 (en) 1982-09-15
CH624967A5 (en) 1981-08-31
SE7706673L (sv) 1978-03-30
ATA151379A (de) 1980-12-15
IL53012A0 (en) 1977-11-30
DE2743069A1 (de) 1978-03-30
JPS6214557B2 (de) 1987-04-02
ATA151279A (de) 1980-12-15
CH631998A5 (en) 1982-09-15
KE3258A (en) 1983-03-04
SE436751B (sv) 1985-01-21
LU75903A1 (de) 1978-05-16
MY8400092A (en) 1984-12-31
CH632000A5 (en) 1982-09-15
DD133150A5 (de) 1978-12-13
DK256977A (da) 1978-03-30
AU514200B2 (en) 1981-01-29
CH625810A5 (en) 1981-10-15

Similar Documents

Publication Publication Date Title
FR2403340A1 (fr) Derives imidazoliques utiles comme medicaments
FR2405946A1 (fr) Nouveaux derives de l'acide 3-methyl-crotonique et procede pour leur preparation
FR2430412A1 (fr) Derives substitues de propanolamine utiles comme medicaments et procede de leur preparation
FR2371437A1 (fr) Nouveaux derives de pipepidine ou de morpholine utiles comme medicaments et comme fongicides
FR2360587A1 (fr) Nouveaux derives d'amino-alcoyl-furannes utiles comme medicaments
FR2378001A1 (fr) Nouveaux cyclohexylcyclohexanes utiles comme derives cristallins liquides
FR2375187A1 (fr) Cyclopentane-1-amines, procede pour leur preparation et produits contenant ces composes
FR2365567A1 (fr) Nouvelles piperazinylpyridines utiles comme medicaments
FR2361370A1 (fr) Nouvelles pyridines substituees, leur preparation et leur application comme medicaments
FR2416892A1 (fr) Derives de pyrido(1,2-a)pyrimidines, procede pour leur preparation et compositions pharmaceutiques qui les contiennent
FR2363559A1 (fr) Nouveaux derives de perhydro-aza-heterocycles utiles comme medicaments et procede pour leur preparation
FR2401144A1 (fr) Derives de benzimidazole contenant du soufre, procede pour leur preparation et intermediaires utiles pour leur production
FR2392999A1 (fr) Nouveaux derives de l'acide 6-((aminosulfonyl)-phenyl)-1,2-dihydro-2-oxonicotinique utile comme medicament
FR2366311A1 (fr) Procede pour la preparation de steroides polyhalogenes utiles comme medicaments
FR2445328A1 (fr) Derives du 14-oxo-e-homo-eburnane, leur procede de preparation et leur utilisation comme medicament
FR2358415A1 (fr) Derives peptidiques, leur preparation et leur application en tant que medicaments
FR2360539A2 (fr) Procede de preparation d'hemi-esters sulfuriques
FR2361346A1 (fr) Dipeptides utiles comme medicaments
FR2365566A1 (fr) Nouveaux derives du thiophene utiles comme medicaments
FR2355819A1 (fr) Procede pour la preparation de composes oxo cycliques
FR2359154A1 (fr) Derives peptidiques utiles comme medicaments et procede pour leur preparation
FR2416893A1 (fr) 2,3-polymethylene-4-oxo-4h-pyrido(1,2-a)pyrimidines utiles comme medicaments et procede pour leur preparation
FR2384770A1 (fr) Nouveaux derives de quinazoline utiles comme medicaments
FR2377382A1 (fr) Nouveaux phenylazacycloalcanes utiles comme medicaments
FR2355011A1 (fr) 2-imino-3-aminothiazolidines utiles comme medicaments

Legal Events

Date Code Title Description
TP Transmission of property